Cushing's Disease: Sustained remission in five cases induced by medical therapy with the dopamine agonist cabergoline

Omayma ElShafie*, Anjum Osman, Fatima Aamer, Ali Al-Mamari, N. J.Y. Woodhouse

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمراجعة النظراء

4 اقتباسات (Scopus)

ملخص

We report five cases of Cushing's disease where the patients were given a therapeutic trial of cabergoline. Morning serum cortisol, adrenocorticotrophic hormone (ACTH), and sleeping cortisol concentrations were significantly raised. Magnetic resonance imaging (MRI) scans revealed pituitary microadenomas in 3 patients but were normal in the others. Ectopic ACTH production was excluded in the 2 patients with normal MRI scans. All were given a therapeutic trial of cabergoline (1 mg daily). Four patients responded with a prompt fall in serum cortisol levels and had a sustained clinical and biochemical remission for 378, 44, 28 and 14 days, respectively. One patient failed to respond. In conclusion, we suggest that all patients with Cushing's disease should undergo a therapeutic trial of cabergoline. Responders can then be prepared for surgery or, if needed, treated medically in the long term.

اللغة الأصليةEnglish
الصفحات (من إلى)493-497
عدد الصفحات5
دوريةSultan Qaboos University Medical Journal
مستوى الصوت12
رقم الإصدار4
المعرِّفات الرقمية للأشياء
حالة النشرPublished - نوفمبر 2012

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700???

بصمة

أدرس بدقة موضوعات البحث “Cushing's Disease: Sustained remission in five cases induced by medical therapy with the dopamine agonist cabergoline'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا